Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: PROCEDURE: CT|DRUG: 18F-FLT|PROCEDURE: PET
Sponsor: National Cancer Institute (NCI)